The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation

Guiyu Xu1, Yuxia Cui1, Zhenghua Jia2

  • 1The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.

Plos One
|November 18, 2016
PubMed

Insights

Coronary circulating microRNAs (miRNAs) reflect atrial fibrillation (AF) regulation. Specific miRNAs in coronary sinus blood and peripheral blood may serve as early diagnostic biomarkers or therapeutic targets for AF patients.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • The precise mechanism of microRNA (miRNA) regulation in atrial fibrillation (AF) remains largely unknown.
  • The role of coronary circulating miRNAs in reflecting myocardial miRNA status in AF patients has not been previously investigated.

Purpose of the Study:

  • To investigate the diagnostic and prognostic value of coronary circulating miRNAs in AF.
  • To explore the differential expression profile of miRNAs in coronary sinus blood (CSB) and peripheral blood (PB) of AF patients compared to healthy controls.

Main Methods:

  • Analysis of miRNA expression profiles in CSB and PB from 90 AF patients and 90 healthy subjects.
  • Comparison of miRNA levels between AF patients and controls using whole-genome analysis.

Main Results:

  • In AF patients, 6 miRNAs were upregulated and 8 downregulated in CSB compared to autologous PB. Notably, miR-1266, miR-4279, and miR-4666a-3p were significantly increased.
  • In PB, 16 miRNAs were upregulated and 24 downregulated compared to normal donors. miR-3171 decreased, while miR-892a and miR-3149 increased significantly with AF progression.

Conclusions:

  • Coronary circulating miRNAs accurately reflect the regulatory status of myocardial miRNAs in AF.
  • Altered miRNA levels in AF patients correlate with disease severity and may serve as potential biomarkers for early diagnosis (miR-892a, miR-3171, miR-3149) and therapeutic targets (miR-1266, miR-4279, miR-4666a-3p).